These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15906367)

  • 1. A modified technique for insertion of intraperitoneal port for chemotherapy.
    Liou WS; Teng NN; Chan JK
    J Surg Oncol; 2005 Jun; 90(4):247-8. PubMed ID: 15906367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administering intraperitoneal chemotherapy using a peritoneal port.
    Doane LS
    Nurs Clin North Am; 1993 Dec; 28(4):885-97. PubMed ID: 8265427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience of a subcutaneously implantable drug delivery catheter (PORT-A-CATH)].
    Kimura K; Koide A; Suga S; Shimoyama T; Okamoto E; Utsunomiya J; Okawa T; Taguchi T; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1150-5. PubMed ID: 3566308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications associated with intraperitoneal chemotherapy catheters.
    Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
    Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
    Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
    Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
    Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
    Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal therapy via the Tenckhoff catheter. Prevention and management of complications.
    Zook-Enck D
    J Intraven Nurs; 1990; 13(6):375-82. PubMed ID: 2243310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal access for intracavitary chemotherapy.
    Howell SB; Pfeifle CE
    Cancer Drug Deliv; 1986; 3(2):157-61. PubMed ID: 3708538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term venous access using a subcutaneous implantable drug delivery system.
    Soo KC; Davidson TI; Selby P; Westbury G
    Ann R Coll Surg Engl; 1985 Jul; 67(4):263-5. PubMed ID: 4037644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 12. Ports and complications for intraperitoneal chemotherapy delivery.
    Helm CW
    BJOG; 2012 Jan; 119(2):150-9. PubMed ID: 22017885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functioning of implantable catheters of intraperitoneal chemotherapy].
    de Gramont A; Marpeau L; Demuynck B; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J; Couturier JY; Delfau S
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):381-5. PubMed ID: 1869783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Walker JL; Armstrong DK; Huang HQ; Fowler J; Webster K; Burger RA; Clarke-Pearson D
    Gynecol Oncol; 2006 Jan; 100(1):27-32. PubMed ID: 16368440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
    Almadrones L
    Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal chemotherapy: technical experience at five institutions.
    Piccart MJ; Speyer JL; Markman M; ten Bokkel Huinink WW; Alberts D; Jenkins J; Muggia F
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):90-6. PubMed ID: 4048981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
    Milczek T; Emerich J; Klasa-Mazurkiewicz D
    Ginekol Pol; 2003 Sep; 74(9):817-23. PubMed ID: 14674130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
    Naumann RW; Sukumvanich P; Edwards RP
    Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of silicone elastomer catheters for long-term intravenous chemotherapy.
    Legha SS; Haq M; Rabinowits M; Lawson M; McCredie K
    Arch Intern Med; 1985 Jul; 145(7):1208-11. PubMed ID: 4015268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus.
    Bryant CS; Shah JP; Triest JA; Schimp VL; Morris RT
    Gynecol Oncol; 2008 Dec; 111(3):552-4. PubMed ID: 18289650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.